NICXF Nicox SA Eur (CE)

0.44

0.00 (0.00%)

03 Jul 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
Nicox SA Eur (CE)	USOTC:NICXF	OTCMarkets	Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%	0.44						0.00	01:00:00

NicOx Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blo

15/09/2008 12:30pm

PR Newswire (US)

Nicox SA Eur (CE) (USOTC:NICXF)
Historical Stock Chart

From Jul 2019 to Jul 2024

Click Here for more Nicox SA Eur (CE) Charts.

PARIS, September 15 /PRNewswire-FirstCall/ -- NicOx S.A. (Euronext Paris: COX) today announced successful top-line results from the second phase 3 study for naproxcinod in 1020 patients with osteoarthritis of the knee (the 302 study). Both doses of naproxcinod (750 mg and 375 mg bid) met the three co-primary efficacy endpoints at week-13 (p